Genomic Vision reported sales results for the third quarter and nine months of 2018. For the nine months, the company’s total revenue from sales amounted to EUR 1.011 million compared to EUR 1.329 million a year ago. Total revenue from activity was EUR 2.141 million compared to EUR 2.214 million a year ago. For the quarter, the company’s total revenue from sales amounted to EUR 0.400 million compared to EUR 0.512 million a year ago. Total revenue from activity was EUR 0.658 million compared to EUR 0.701 million a year ago.